Dr. Herman C. Sullivan, MD

Dr. Sullivan practices at Trinity Health Grand Rapids Hospital in Grand Rapids, Michigan, part of Trinity Health.

Dr. Sullivan's NPI, 1528008281, was assigned on June 8, 2006. Dr. Sullivan holds Michigan license 4301069347.

Dr. Sullivan's primary practice is Trinity Health Grand Rapids Hospital, at 200 Jefferson Avenue SE, Grand Rapids, MI 49503 in Kent County. The practice phone is (616) 685-5000.

Dr. Sullivan's primary practice is Trinity Health Grand Rapids Hospital in Grand Rapids, Michigan, part of Trinity Health. Dr. Sullivan is also affiliated with Trinity Health Muskegon Hospital. The medical group on file is Trinity Health Medical Group. Dmand AI also links Dr. Sullivan to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sullivan practices, 3 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Sullivan's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Sullivan is licensed in Michigan.

CMS data shows 55 Medicare services from Dr. Sullivan across 3 procedure codes in 2024, all of them office visits, for 65 Medicare patients. Medicare paid $3,422 for them.

CMS counts 65 Medicare patients who saw Dr. Sullivan in 2024. The largest group is under 65, with 32 patients. 57% of them have high cholesterol, and 54% have high blood pressure. 25% are also on Medicaid. Their average risk score is 1.61, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sullivan's median patient age at 56, with 68% women.

In 2024, Dr. Sullivan wrote 1,462 Medicare Part D claims for 153 patients. 91% of them were for generic drugs. CMS names the drug for 1,256 of them, across 33 drugs with 11 or more claims each, at $1,700,518 in total drug cost. In 2023, CMS named 1,381 claims across 34 drugs.

Dr. Sullivan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sullivan as offering telehealth.

CMS Open Payments shows 77 general payments to Dr. Sullivan from 21 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 49% of the total. Teva Pharmaceuticals USA, Inc. paid the most, $14,640. It also lists 14 research payments totaling $2,478 in 2024, naming 1 clinical trial.